1/1
2 files

Utility calculator for visual acuity

Please see readme.txt

Funding

A multicentre double-masked randomised non-inferiority clinical trial comparing the clinical and cost-effectiveness of intravitreal ranibizumab (Lucentis), aflibercept (Eylea) and bevacizumab (Avastin) for Macular Oedema due to Central Retinal Vein Occlusion (acronym: LEAVO)

NIHR Evaluation Trials and Studies Coordinating Centre

Find out more...

History